Shares of Hanwha Q Cells Co. Ltd. (NASDAQ:HQCL) have received an average broker rating score of 3.00 (Hold) from the one brokers that provide coverage for the stock, Zacks Investment Research reports. One equities research analyst has rated the stock with a hold recommendation. Hanwha Q Cells Co.’s rating score has declined by 200% from 90 days ago as a result of various analysts’ ratings changes.
Analysts have set a 12-month consensus target price of $13.00 for the company and are expecting that the company will post $0.21 earnings per share for the current quarter, according to Zacks. Zacks has also assigned Hanwha Q Cells Co. an industry rank of 103 out of 265 based on the ratings given to its competitors.
A number of research analysts have weighed in on the stock. Zacks Investment Research cut shares of Hanwha Q Cells Co. from a “hold” rating to a “strong sell” rating in a report on Tuesday, August 9th. Roth Capital cut shares of Hanwha Q Cells Co. from a “buy” rating to a “neutral” rating in a report on Friday, August 5th.
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Walleye Trading LLC raised its stake in shares of Hanwha Q Cells Co. by 1,166.7% in the second quarter. Walleye Trading LLC now owns 7,600 shares of the company’s stock valued at $109,000 after buying an additional 7,000 shares during the period. AJO LP bought a new stake in shares of Hanwha Q Cells Co. during the second quarter valued at about $171,000. Oxford Asset Management bought a new stake in shares of Hanwha Q Cells Co. during the second quarter valued at about $392,000. Barclays PLC bought a new stake in shares of Hanwha Q Cells Co. during the first quarter valued at about $432,000. Finally, Guggenheim Capital LLC raised its stake in shares of Hanwha Q Cells Co. by 27.8% in the second quarter. Guggenheim Capital LLC now owns 493,596 shares of the company’s stock valued at $7,108,000 after buying an additional 107,408 shares during the period. 1.59% of the stock is owned by institutional investors.
Shares of Hanwha Q Cells Co. (NASDAQ:HQCL) traded down 2.70% during mid-day trading on Tuesday, hitting $11.52. 9,536 shares of the stock traded hands. The company has a market cap of $958.26 million, a P/E ratio of 5.24 and a beta of 2.21. The firm has a 50 day moving average of $11.71 and a 200 day moving average of $12.93. Hanwha Q Cells Co. has a 12 month low of $10.35 and a 12 month high of $28.87.
Hanwha Q Cells Co. (NASDAQ:HQCL) last issued its earnings results on Tuesday, August 23rd. The company reported $0.92 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.48 by $0.44. Hanwha Q Cells Co. had a net margin of 8.03% and a return on equity of 42.12%. The firm earned $638 million during the quarter, compared to analysts’ expectations of $646 million. During the same quarter last year, the company posted ($0.17) earnings per share. The firm’s revenue was up 88.8% compared to the same quarter last year. Equities analysts anticipate that Hanwha Q Cells Co. will post $1.67 EPS for the current fiscal year.
Hanwha Q Cells Co. Company Profile
Hanwha Q CELLS Co, Ltd., formerly Hanwha SolarOne Co, Ltd., is a global solar energy company engaged in the manufacturing of solar modules, and the development and management of downstream solar farms. It manufactures a range of photo voltaic (PV) cells and PV modules at its manufacturing facilities in China and Malaysia using manufacturing process technologies, including those developed at its research and development facilities in Germany.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Hanwha Q Cells Co. Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hanwha Q Cells Co. Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.